Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Locally delivered clindamycin gel as an adjunct to scaling and root debridement in periodontitis
PACTR202506804878602Phase 3Recruiting
- Sponsor
- Daniel Chukwuma
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of clindamycin in periodontitis (2 arms), sponsored by Daniel Chukwuma. Primary endpoints: Probing pocket depth at 3 months and Clinical attachment level at 3 months. Started Jun 2025; status: recruiting.
02
Drugs
clindamycin
03
Conditions
periodontitis
Beyond the preview
Go deeper on PACTR202506804878602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506804878602.